Pfizer to invest more than 6 million euros in their Catalan plant, “a worldwide reference” in vaccines for animals
The factory will increase its output of biological and pharmaceutical products by 40% over 3 years, taking work from closing factories in Europe and the United States. The Catalan plant is specialised in animal health and vaccines for livestock. It was bought in 2009 by the North American pharmaceutical giant, in a small town near Girona.